BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30180941)

  • 1. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
    McClellan K; Temples H; Miller L
    J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol; 2018 May; 131(5):e130-e139. PubMed ID: 29683910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providing Long-acting Reversible Contraception to Adolescents: A Review.
    Bahar YZ; Gold MA
    Clin Obstet Gynecol; 2020 Sep; 63(3):561-573. PubMed ID: 32452845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective, recommended, underutilized: a review of the literature on barriers to adolescent usage of long-acting reversible contraceptive methods.
    Coles CB; Shubkin CD
    Curr Opin Pediatr; 2018 Oct; 30(5):683-688. PubMed ID: 30028744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Pediatricians Provide Long-Acting Reversible Contraception?
    Norris AH; Pritt NM; Berlan ED
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
    Dodson NA; Gray SH; Burke PJ
    Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.
    Buckingham P; Moulton JE; Subasinghe AK; Amos N; Mazza D
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):629-640. PubMed ID: 33608901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interdependent Barriers to Providing Adolescents with Long-Acting Reversible Contraception: Qualitative Insights from Providers.
    Murphy MK; Stoffel C; Nolan M; Haider S
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):436-442. PubMed ID: 26851537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Acting Reversible Contraception for Adolescents: A Review.
    Francis JKR; Gold MA
    JAMA Pediatr; 2017 Jul; 171(7):694-701. PubMed ID: 28558091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent Long-Acting Reversible Contraceptive Use, Same-Day Insertions, and Pregnancies Following a Quality Initiative.
    Bruce KH; Merchant MA; Kaskowitz AP; Mickelsen RS; Lau JS
    J Adolesc Health; 2023 Nov; 73(5):946-952. PubMed ID: 37436353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.
    Kortsmit K; Williams L; Pazol K; Smith RA; Whiteman M; Barfield W; Koumans E; Kourtis A; Harrison L; Bauman B; Warner L
    JAMA Pediatr; 2019 Jul; 173(7):663-670. PubMed ID: 31107513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to Health Care Providers' Provision of Long-Acting Reversible Contraception to Adolescent and Nulliparous Young Women.
    Hopkins B
    Nurs Womens Health; 2017; 21(2):122-128. PubMed ID: 28388997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Solutions to Improve Adolescent Intrauterine Device Access.
    Espey E; Yoder K; Hofler L
    J Pediatr Adolesc Gynecol; 2019 Sep; 32(5S):S7-S13. PubMed ID: 31585618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let's talk about sex (again): advancing the conversation around long-acting reversible contraception for teenagers.
    Satterwhite CL; Ramaswamy M
    Womens Health (Lond); 2015 Nov; 11(6):841-50. PubMed ID: 26626398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
    Diedrich JT; Klein DA; Peipert JF
    Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception.
    Aligne CA; Phelps R; VanScott JL; Korones SA; Greenberg KB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S890.e1-S890.e6. PubMed ID: 31978438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.